You will be redirected to:

Continue
Logo - Kls
Logo - Kls
  • Playbook
  • Services
    Services
    Delivery models
  • Insights
  • Technology
  • Careers
  • About us
    Company purpose
    Life science innovation
    Committed Keyrus
    Regulatory compliance
    Investors
    Management team
    Keyrus Group
    Locations

Managing efficiently a large cohort RWE study, thanks to dedicated apparatus

<5 days

average time before data monitoring

90%

exploitable visits

6 months

time between the LPLV & the Clinical Study Report

Background

Our client is the french subsidiary of a major international pharmaceutical company (Top 5), operating in more than 150 countries, in a wide variety of therapeutic areas, in particular Oncology, Cardiology and Ophthalmology. Wishing to set up a RWE study on the french market, this client chose us for our agility and capacity to adapt, essential for such a study.

Challenge

The objective of the study was to better understand 'in real life' care management habits for patients suffering from heart failure, and referred for the first time/rarely to their cardiologist. Such a RWE study was performed to help the client optimizing its marketing strategies, in conjunction with healthcare professionals.

Approach

To achieve this objective, a large-scale national multicenter study (150 centers, 1600 patients) has been set up. Keyrus Life Science carried out all the activities required for the study: regulatory submissions, recruitment of investigator cardiologists, follow-up of patient recruitment, remote (or not) monitoring of the data, data management & statistical analyses, clinical report and presentation of the results.

Key results

01
Selection of the 150 most appropriate investigator cardiologists for the study (among 4500 contacted)
02
Sufficient patient recruitment to statistically evaluate the primary objective, despite the epidemic context that impacted the study
03
Management of the monitoring activities in compliance with the schedule, thanks to agile processes adapted to the study challenges (dedicated CRAs, TEC visits, mixed paper-electronic CRF)

Benefits

Satisfied with the overall management of the study and the results obtained, the client emphasized the performance of the Keyrus Life Science teams, both in terms of setting up a structure adapted to the study recruitment goals and in response to the Covid context. The better disease understanding, gained throw this study, helped the client building an optimized market access strategy.

Technology partners

Marvin - XClinical

Share this key play

whatsapptwitter
linkedinfacebookworkplace

Ready for your own success story?

Get in touch with our team of experts.



I acknowledge having read the privacy policy.

Keyrus collects and processes the data you fill out in this form in order to respond to your request and for commercial prospecting purposes. The fields marked with an asterisk must be filled in for your request to be processed. To learn more about how we manage your personal data and to exercise your rights, please refer to the Privacy Policy. By clicking on Submit, I acknowledge that I have read and accepted the legal notice and the general terms of use of the site.

More key plays

Adapting service platforms (FSP) functionning to fit the client's new outsourcing strategy
Facilitate the provision of an innovative treatment thanks to a Managed Access Program (MAP)
Efficiently conducting a worldwide phase 2 clinical study with multiple partners
Achieving an end-to-end audit approval from Health Canada
Facilitate data mapping to SDTM by leveraging standardisation and A.I.
Speed up the development of clinical study documents
Transforming pediatric care through digital enablement
Medical device approved for Hearing Loss
Piloting through a pivotal study in cataract eye surgery helping patients recover their vision
Logo - Kls
Headquarters

155 rue Anatole France 92593 Levallois-Perret

Phone:+33 (0)1 41 34 10 00

Fax:+33 (0)1 41 34 10 10

LinkedInKlsInstagram
PlaybookServicesInsightsTechnologyCareersAbout us
Company purposeLife science innovationCommitted KeyrusRegulatory complianceInvestorsManagement teamKeyrus GroupLocations
Legal notice & Terms of use
Privacy policy
Data protection